{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04314661",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CT/OA/01/2020"
      },
      "Organization": {
        "OrgFullName": "PT. Prodia Stem Cell Indonesia",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Comparative Effectiveness of Arthroscopy and Non-Arthroscopy Using Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium for Osteoartrithis",
      "OfficialTitle": "Comparative Effectiveness of Arthroscopy and Non-Arthroscopy Using Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium From Mesenchymal Stem Cell Culture (MSCs) for Osteoartrithis With Controlled Randomization in Phase I/II",
      "Acronym": "OA"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "August 3, 2020",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 8, 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 8, 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "February 19, 2020",
      "StudyFirstSubmitQCDate": "March 17, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 19, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "July 14, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "July 15, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "PT. Prodia Stem Cell Indonesia",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The clinical trial will be carried out at the Gatot Soebroto Army Central Hospital, Jakarta and planned from October 2019 to April 2020. Clinical trials of UC-MSCs and CM UC MSCs against OA were designed in three groups with arthroscopy and without arthroscopy with each of the groups 1 and 2 were given 5 million UC-MSCs cells then continued with 2 cc UC-MSCs CM given twice at 2-week intervals, while group 3 were given 2cc CM-MSCs and continued with 2-cm CM-MSCs administration at intervals 2 weeks. The study subjects each group amounted to 5 patients suffering from osteoarthritis. Once a week, all subjects were given physiotherapy by a doctor. Patients were evaluated for 6 months after injection.\n\nThe hypothesis are\n\nThere is an optimum improvement to the arthroscopy compared to without arthroscopy using UC-MSCs and CM UC-MSCs in osteoarthritis sufferers\nReduced pain during joint rehabilitation and inflammation using UC-MSCs and CM UC-MSCs in patients with osteoarthritis.\nThere are differences in functional scores of the knee joint after therapy using UC-MSCs and CM UC-MSCs in patients with osteoarthritis.\nThere are differences in levels of inflammatory enzymes after therapy using UC-MSCs and CM UC-MSCs in patients with osteoarthritis.\nThere is a significant relationship between improvement in functional score of the knee joint with levels of inflammatory enzymes in osteoarthritis"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteoarthritis, Knee"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Osteoarthritis",
          "Allogeneic Mesenchymal Stem Cells",
          "Umbilical Cord",
          "Conditioned Medium"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "15",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Arthoscopy + UC-MSCs + CM + CM",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "After arthroscopy patient will be given UC-MSCs 5 million cells, after 2 weeks patient will be given CM 2 cc and after 2 weeks later the patient will be given CM 2 cc",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stem Cells with Arthoscopy"
              ]
            }
          },
          {
            "ArmGroupLabel": "Non Arthoscopy + UC-MSCs + CM + CM",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patient will be given UC-MSCs 5 million cells, after 2 weeks patient will be given CM 2 cc and after 2 weeks later the patient will be given CM 2 cc",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stem Cells with Arthoscopy",
                "Biological: Mesenchymal Stem Cells without Arthoscopy"
              ]
            }
          },
          {
            "ArmGroupLabel": "Non Arthoscopy + CM + CM",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Patient will be given CM 2 cc and after 2 weeks later the patient will be given CM 2 cc",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stem Cells without Arthoscopy",
                "Biological: Conditioned Medium without Arthoscopy"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal Stem Cells with Arthoscopy",
            "InterventionDescription": "Arthroscopy treatment after that injection Allogeneic Umbilical Cord Mesenchymal Stem Cells 5 million cells in NaCL 5 cc, two weeks later injection with Conditioned Medium 2 cc/knee, four weeks later injection with Conditioned Medium 2 cc/knee. All injection via Intraarticular injection.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Arthoscopy + UC-MSCs + CM + CM",
                "Non Arthoscopy + UC-MSCs + CM + CM"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal Stem Cells without Arthoscopy",
            "InterventionDescription": "Injection with Allogeneic Umbilical Cord Mesenchymal Stem Cells 5 million cells in NaCL 5 cc, two weeks later injection with Conditioned Medium Derived Umbilical Cord Mesenchymal Stem Cells 2 cc/knee, four weeks later injection with Conditioned Medium 2 cc/knee. All injection via Intraarticular injection.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Non Arthoscopy + CM + CM",
                "Non Arthoscopy + UC-MSCs + CM + CM"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Conditioned Medium without Arthoscopy",
            "InterventionDescription": "Injection with Conditioned Medium Derived Umbilical Cord Mesenchymal Stem Cells 2 cc/knee, four weeks later injection with Conditioned Medium 2 cc/knee. All injection via Intraarticular injection.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Non Arthoscopy + CM + CM"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Secretome"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Visual Analog Scale (VAS)",
            "PrimaryOutcomeDescription": "To asses pain score, score 1(good)-10(worst)",
            "PrimaryOutcomeTimeFrame": "1 month after injection"
          },
          {
            "PrimaryOutcomeMeasure": "Visual Analog Scale (VAS)",
            "PrimaryOutcomeDescription": "To asses pain score, score 1(good)-10(worst)",
            "PrimaryOutcomeTimeFrame": "2 month after injection"
          },
          {
            "PrimaryOutcomeMeasure": "Visual Analog Scale (VAS)",
            "PrimaryOutcomeDescription": "To asses pain score, score 1(good)-10(worst)",
            "PrimaryOutcomeTimeFrame": "6 month after injection"
          },
          {
            "PrimaryOutcomeMeasure": "Western Ontario and McMaster Universities Osteoarthritis Index",
            "PrimaryOutcomeDescription": "To evaluate the condition of patients with osteoarthritis, including pain, stiffness, and physical functioning of the joints.",
            "PrimaryOutcomeTimeFrame": "1 month after injection"
          },
          {
            "PrimaryOutcomeMeasure": "Western Ontario and McMaster Universities Osteoarthritis Index",
            "PrimaryOutcomeDescription": "To evaluate the condition of patients with osteoarthritis, including pain, stiffness, and physical functioning of the joints.",
            "PrimaryOutcomeTimeFrame": "2 month after injection"
          },
          {
            "PrimaryOutcomeMeasure": "Western Ontario and McMaster Universities Osteoarthritis Index",
            "PrimaryOutcomeDescription": "To evaluate the condition of patients with osteoarthritis, including pain, stiffness, and physical functioning of the joints.",
            "PrimaryOutcomeTimeFrame": "6 month after injection"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Laboratory Asessment",
            "SecondaryOutcomeDescription": "COMP, MMP-13, IL-6",
            "SecondaryOutcomeTimeFrame": "6 weeks after injection"
          },
          {
            "SecondaryOutcomeMeasure": "Laboratory Asessment",
            "SecondaryOutcomeDescription": "COMP, MMP-13, IL-6",
            "SecondaryOutcomeTimeFrame": "12 weeks after injection"
          },
          {
            "SecondaryOutcomeMeasure": "Laboratory Asessment",
            "SecondaryOutcomeDescription": "COMP, MMP-13, IL-6",
            "SecondaryOutcomeTimeFrame": "24 weeks after injection"
          },
          {
            "SecondaryOutcomeMeasure": "Magnetic Resonance Imaging (MRI) T2 mapping",
            "SecondaryOutcomeDescription": "MRI T2 mapping is used for cartilage evaluation",
            "SecondaryOutcomeTimeFrame": "6 month after injection"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients aged 55-70 years\nSuffering from grade 3 OA was identified by two observers who differed accordingly Kellgren-Lawrence research scale\nAbsence of local or general infections\nHaematological and biochemical analysis without significant changes being made cause contraindications\nPatients can understand the nature of the study\nWritten informed consent is given to patients\n\nExclusion Criteria:\n\nPatients are not willing to obey the study protocol\nThere are signs of infection or positive serology for HIV, hepatitis and syphilis\nThere is a history of cancer both in the family and yourself and the value of the examination tumour marker exceeds normal limits\nThere is a congenital disease that causes significant deformity of the knee can interfere with cell applications and interpret results\nArticular injection of the knee by any drug during the previous 3 months\nParticipate in any clinical trial or treatment 30 days before the study\nOther conditions may, according to medical criteria, not support participation in this research\nPatients are subordinates or low ranking members",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "55 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Yanuarso Yanuarso, Master",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "081317128172",
            "CentralContactEMail": "dryanuarso73@gmail.com"
          },
          {
            "CentralContactName": "Cynthia Sartika, Doctor",
            "CentralContactRole": "Contact",
            "CentralContactEMail": "c.sartika@gmail.com"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Gatot Soebroto Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Jakarta Pusat",
            "LocationState": "DKI Jakarta",
            "LocationZip": "10410",
            "LocationCountry": "Indonesia",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Yanuarso, dr",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "08170147000",
                  "LocationContactEMail": "dryanuarso73@gmail.com"
                },
                {
                  "LocationContactName": "Viana",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "081317128172",
                  "LocationContactEMail": "rahmawativiana@gmail.com"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Osteoarthritis, Knee",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}